Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/1999
11/04/1999CA2323759A1 Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase
11/03/1999EP0953646A2 Herbicide tolerant transgenic plants where the herbicide inhibits prophyrin biosynthesis
11/03/1999EP0953644A1 Systems for the mass production of proteins or peptides by microorganisms of the genus humicola
11/03/1999EP0953643A2 Raffinose synthase genes and their use
11/03/1999EP0953635A1 Improved methods for extracting nucleic acids from tissue samples and paraffin-embedded tissues
11/03/1999EP0953634A1 Composition for treating porous article, treatment method, and use thereof
11/03/1999EP0953572A2 Peptides binding to bone marrow stromal cell antigen
11/03/1999EP0953044A2 Gene for adenylate cyclase and its use
11/03/1999EP0953043A1 Genes and gene products related to werner's syndrome
11/03/1999EP0953041A1 Serum-free mammalian cell culture medium, and uses thereof
11/03/1999EP0953037A1 A mutant e. coli strain with increased succinic acid production
11/03/1999EP0952979A1 Production of xylanase and cellulase in b. subtilis
11/03/1999EP0952847A1 Stable biocatalysts for ester hydrolysis
11/03/1999EP0952767A1 Production of somatic mosaicism in mammals using a recombinatorial substrate
11/03/1999EP0763055B1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
11/03/1999EP0401303B2 Novel human tissue plasminogen activator variants and processes
11/03/1999EP0371998B2 Modular assembly of antibody genes, antibodies prepared thereby and use
11/03/1999CN1234074A Method for preparing 2-hydroxy 4-methylthio butyric acid using nitrilase
11/03/1999CN1234070A Peniophora phytase
11/03/1999CN1234038A C-end modified (N-subsd.)-2-indyldipeptide used for ICE/ced-3 family cysteine protein enzyme inhibitor
11/03/1999CN1233661A L-glutamic acid-producing bacterium and method for producing L-glutamic acid
11/03/1999CN1233660A L-glutamic acid-producing bacterium and method for producing L-glutamic acid
11/03/1999CN1046136C Coated enzyme composition for washing and cleaning products
11/02/1999US5978740 Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them
11/02/1999US5977442 Salicylic acid induced map kinase and its use for enhanced disease resistance in plants
11/02/1999US5977440 For genetically engineered plants which are resistant to leptidopteran feeding; for imparting sterility to male of plant species; biological pest control
11/02/1999US5977439 Binary BAC vector
11/02/1999US5977438 Production of peptides in plants as viral coat protein fusions
11/02/1999US5977437 Genetically engineered starch producing plant or alga which produces exogenous plant or algal adenosine diphosphate-glucose pyrophosphorylase; for increased starch yield
11/02/1999US5977436 Nucleic acid which directs seed-specific expression of linked heterologous nucleic acid; for expression cassettes and vectors to modulate fatty acid synthesis or lipid metabolism in transformed plants
11/02/1999US5977435 Plant phosphatases
11/02/1999US5977331 α-Ketoglutarate dehydrogenase gene
11/02/1999US5977320 Antibody to novel human phosphorylase kinase gamma subunit
11/02/1999US5977317 Failure of cells to precisely control their replicative state therefore leads to a variety of diseases of pathological proliferation, including cancers and atherosclerosis.
11/02/1999US5977314 Catalytic antibodies against cocaine
11/02/1999US5977308 Platelet-activating factor acetylhydrolase
11/02/1999US5977307 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
11/02/1999US5977305 Cloning by complementation and related processes
11/02/1999US5977085 Vectors carrying coding sequence for the SpsB protein of Staphylococcus aureus
11/02/1999US5977065 Bacterial nitroreductase for the reduction of CB1954 and analogues thereof to a cytotoxic form
11/02/1999US5977056 Treatment of thrombotic events
11/02/1999US5976893 Methods for identifying binding partners, agonists, and antagonist of a serine/threonine tyrosine kinase
11/02/1999US5976875 Diacylglycerol kinase isoforms epsilon and zeta and methods of use thereof
11/02/1999US5976869 DNA sequences and plasmids for the preparation of plants with changed sucrose concentration
11/02/1999US5976866 Screen for inhibitors of fungal IPC synthase
11/02/1999US5976862 Process for obtaining DNA, RNA, peptides, polypeptides, or proteins, by recombinant DNA technique
11/02/1999US5976859 Compositions for cleaning and washing purposes.
11/02/1999US5976857 Enzyme donor polypeptide with two cysteines linked by disulfide bond which prevents polypeptide forming an active enzyme complex and has inserted recognition site for specific enzyme that when cleaved allows complementation
11/02/1999US5976856 Recombinant thermostable enzyme which forms non-reducing saccharide from reducing amylaceous saccharide
11/02/1999US5976855 Method of preparing a variant of a lipolytic enzyme
11/02/1999US5976854 Calcium independent cytosolic phospholipase A2 /B enzymes
11/02/1999US5976853 Fibroblast growth factor inducible hydrolase enzyme; for antiproliferative/anticarcinogenic/antitumor agents; treatment of psoriasis, benign prostatic hypertrophy, cutaneous fungal infections, hyperplasia; contraceptives
11/02/1999US5976852 Isolated nucleic acid molecule encoding a receptor protein; for identifying agonists and antagonists; treatment of paralytic disease; antitumor/antimetastasis agents
11/02/1999US5976851 Methods and compositions for the identification, characterization, and inhibition of farnesyl protein transferase
11/02/1999US5976850 Hippocampus-associated proteins; DNA sequences coding therefor and uses thereof
11/02/1999US5976849 Human E3 ubiquitin protein ligase
11/02/1999US5976848 Method of identifying potential fungicides using dihydroorotate dehydrogenase inhibition assay
11/02/1999US5976844 Riboflavin-production process by means of micro-organisms with modified isocitratlyase activity
11/02/1999US5976841 Proteins having fibrinolytic and coagulation--inhibiting properties
11/02/1999US5976840 Polynucleotides encoding gluS polypeptides of streptococcal pneumoniae
11/02/1999US5976833 Relates to a method of producing protein or peptide by the culture of recombinant cells.
11/02/1999US5976830 Methods of producing doxorubicin
11/02/1999US5976804 The use of these sequences in the diagnosis, treatment, and prevention of cancer, immune disorders, and myopathies.
11/02/1999US5976803 Genetic test for equine severe combined immunodeficiency disease
11/02/1999US5976800 Enhancement of cancer cell death
11/02/1999US5976796 The gene product alone can be sufficient to allow detection of living cells under the light microscope.
11/02/1999US5976794 Method for molecular staging of prostate cancer
11/02/1999US5976781 Diagnosing malaria by mixing blood with enzyme inhibitor, determining enzyme activity, comparing to control sample; plasmodium enzyme is more sensitive to inhibition so deactivation indicates disease
11/02/1999US5976546 Antigen presenting cells activated by contact with a polypeptide complex constructed by joining together a dendritic cell-binding protein and a polypeptide antigen.
11/02/1999US5976542 Bacterial enzymes as targets for antibiotic therapy and as bacterial vaccines.
11/02/1999US5976530 Peptide plasminogen activators
11/02/1999US5976529 Methods of enzyme therapy by orally administering crosslinked enzyme crystals
11/02/1999US5976528 Used to decrease the risk of chemical carcinogenesis comprising administering to a subject in need of such treatment an effective amount.
11/02/1999US5976527 High surface area support having bound latex particles containing oxirane groups for immobilization of substances
11/02/1999US5975095 Enzymatic detergent composition and method for degrading and removing bacterial cellulose and glycerides
11/02/1999CA2171331C Synthesis of catechol from biomass-derived carbon sources
11/02/1999CA2119443C Human cyclin e
11/02/1999CA2002788C Adp glucose-pyrophosphorylase
10/1999
10/30/1999CA2775100A1 Method for giving resistance to weed control compounds to plants
10/28/1999WO1999054735A1 Improved immunodiagnostic assays using reducing agents
10/28/1999WO1999054495A1 Assay for screening inhibitors of c4 plant enzymes
10/28/1999WO1999054490A2 Plant-derived resistance gene
10/28/1999WO1999054486A1 Canine erythropoietin gene and recombinant protein
10/28/1999WO1999054483A1 Gene of rice dihydrodipicolinate synthase and dna relating to the same
10/28/1999WO1999054482A1 Dna fragmentation factor involved in apoptosis
10/28/1999WO1999054481A1 Mutant having uracil phosphoribosyl transferase activity
10/28/1999WO1999054480A1 Transgenic plants presenting a modified inulin producing profile
10/28/1999WO1999054479A2 INHIBITION OF ALKYL HYDROPEROXIDE REDUCTASE, SUBUNIT C (AhpC) TO IMPART SUSCEPTIBILITY TO ANTIMICROBIAL REACTIVE NITROGEN INTERMEDIATES
10/28/1999WO1999054478A1 Gene encoding protein having aurone synthesizing activity
10/28/1999WO1999054477A2 Genetically engineered yeast and mutants thereof for the efficient fermentation of lignocellulose hydrolysates
10/28/1999WO1999054476A1 Penicillin conversion
10/28/1999WO1999054475A2 Identification of lactic acid bacterial genes involved in the biosynthesis of exopolysaccharides
10/28/1999WO1999054471A1 Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata
10/28/1999WO1999054459A2 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
10/28/1999WO1999054455A1 Method for synthesizing dna
10/28/1999WO1999054453A1 Novel genetically modified lactic acid bacteria having modified diacetyl reductase activities
10/28/1999WO1999054452A1 Methods and substances for preventing and treating autoimmune disease
10/28/1999WO1999054450A1 Assay methods for modulators of hematopoietic cell phosphatase
10/28/1999WO1999054449A2 Dyskerine and dyskerine coding dna molecule, vectors containing the same, antibodies against dyskerin and utilization of said elements
10/28/1999WO1999054443A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep
1 ... 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 ... 1416